- Home
- XPL vs SER Comparison
XPL vs SER Comparison
Compare XPL & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPL
- SER
- Stock Information
- Founded
- XPL 1984
- SER 2017
- Country
- XPL United States
- SER United States
- Employees
- XPL N/A
- SER N/A
- Industry
- XPL Precious Metals
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- XPL Basic Materials
- SER Health Care
- Exchange
- XPL Nasdaq
- SER Nasdaq
- Market Cap
- XPL 47.9M
- SER 56.5M
- IPO Year
- XPL N/A
- SER 2018
- Fundamental
- Price
- XPL $0.73
- SER $5.41
- Analyst Decision
- XPL Strong Buy
- SER Strong Buy
- Analyst Count
- XPL 1
- SER 2
- Target Price
- XPL $1.20
- SER $13.00
- AVG Volume (30 Days)
- XPL 126.4K
- SER 24.8K
- Earning Date
- XPL 08-06-2025
- SER 08-11-2025
- Dividend Yield
- XPL N/A
- SER N/A
- EPS Growth
- XPL N/A
- SER N/A
- EPS
- XPL N/A
- SER N/A
- Revenue
- XPL N/A
- SER $130,000.00
- Revenue This Year
- XPL N/A
- SER N/A
- Revenue Next Year
- XPL N/A
- SER N/A
- P/E Ratio
- XPL N/A
- SER N/A
- Revenue Growth
- XPL N/A
- SER N/A
- 52 Week Low
- XPL $0.54
- SER $3.81
- 52 Week High
- XPL $0.89
- SER $10.28
- Technical
- Relative Strength Index (RSI)
- XPL 59.06
- SER 50.71
- Support Level
- XPL $0.65
- SER $5.02
- Resistance Level
- XPL $0.74
- SER $5.63
- Average True Range (ATR)
- XPL 0.02
- SER 0.39
- MACD
- XPL 0.00
- SER 0.03
- Stochastic Oscillator
- XPL 81.43
- SER 35.48
About XPL Solitario Resources Corp.
Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.